ELAB - Multiplikator Forward P/S Elevai Labs

Logo korporat perusahaan Elevai Labs Inc. (ELAB)

Elevai Labs Inc. (ELAB) relies on rigorous cold-chain bio-logistics and loyalty within the B2B aesthetic medicine sector. The GURU.Markets portal provides this chart, where the forward P/S ratio demonstrates valuation dynamics, and the 0.50 level represents the current value. Growth prospects are based on the recognition of exosome technologies by cosmetologists and an increase in recurring orders from specialized clinics.

ELAB (elevaiskincare.com) riwayat Rasio rega marang prakiraan pendapatan saka 21.02.2024 nganti 14.11.2026

Rincian analitis perusahaan Elevai Labs Inc.

- rega pasar lan target rega analis:
Ringkesan analisis perusahaan:ELAB (Elevai Labs)
Sampel barang elevaiskincare.com

This indicator serves as an asset stress-testing tool, allowing for the determination of the degree of overpayment for future business growth rates. The metric compares the current market value of Elevai Labs Inc. (ELAB) with expected sales volume; therefore, analyzing the projected market cap-to-revenue ratio is critical amid fierce competition with luxury brands capable of eroding the uniqueness of the company's biotechnological formulas.